Rocket Pharmaceuticals, Inc.Company Review & Valuation

RCKT
Nasdaq
Latest Price
27.94USD
Market Capitalization
1,538.69mUSD

About Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It has two lentiviral vector (LVV) programs under clinical testing to treat fanconi anemia, a genetiShow morec defect in the bone marrow that reduces production of blood cells; and three LVV programs for the treatment of other rare genetic diseases, as well as an adeno-associated viral vector program, which is under preclinical development. The company has collaboration agreements with Lund University, Sweden; and Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, as well as a strategic research collaboration agreement with Stanford University School of Medicine. Rocket Pharmaceuticals, Inc. is headquartered in New York, New York.Show less

Industry
Biotechnology
HQ Location
New York, New York

Stock Price

Price data not available for Rocket Pharmaceuticals, Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Biogen
Jazz Pharmaceuticals
Vernalis
Kalytera Therapeutics

back to top